메뉴 건너뛰기




Volumn 34, Issue 2, 2009, Pages 121-130

Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007)

Author keywords

Acinetobacter; Antimicrobial resistance; Longitudinal surveillance; MRSA; Tigecycline

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; MINOCYCLINE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; VANCOMYCIN;

EID: 67349169225     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.02.003     Document Type: Article
Times cited : (45)

References (27)
  • 1
    • 40449096647 scopus 로고    scopus 로고
    • Strategies for managing today's infections
    • Carmeli Y. Strategies for managing today's infections. Clin Microbiol Infect 14 Suppl 3 (2008) 22-31
    • (2008) Clin Microbiol Infect , vol.14 , Issue.SUPPL. 3 , pp. 22-31
    • Carmeli, Y.1
  • 2
    • 40449128870 scopus 로고    scopus 로고
    • Evolving problems with resistant pathogens
    • Chastre J. Evolving problems with resistant pathogens. Clin Microbiol Infect 14 Suppl 3 (2008) 3-14
    • (2008) Clin Microbiol Infect , vol.14 , Issue.SUPPL. 3 , pp. 3-14
    • Chastre, J.1
  • 3
    • 39049134890 scopus 로고    scopus 로고
    • Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species
    • Gupta V. Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species. Expert Opin Investig Drugs 17 (2008) 131-143
    • (2008) Expert Opin Investig Drugs , vol.17 , pp. 131-143
    • Gupta, V.1
  • 4
    • 9544247854 scopus 로고    scopus 로고
    • Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet(M)- and Tet(O)-mediated ribosomal protection
    • Bergeron J., Ammirati M., Danley D., James L., Norcia M., Retsema J., et al. Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet(M)- and Tet(O)-mediated ribosomal protection. Antimicrob Agents Chemother 40 (1996) 2226-2228
    • (1996) Antimicrob Agents Chemother , vol.40 , pp. 2226-2228
    • Bergeron, J.1    Ammirati, M.2    Danley, D.3    James, L.4    Norcia, M.5    Retsema, J.6
  • 5
    • 23644449559 scopus 로고    scopus 로고
    • Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004)
    • Fritsche T.R., Sader H.S., Stilwell M.G., Dowzicky M.J., and Jones R.N. Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004). Diagn Microbiol Infect Dis 52 (2005) 195-201
    • (2005) Diagn Microbiol Infect Dis , vol.52 , pp. 195-201
    • Fritsche, T.R.1    Sader, H.S.2    Stilwell, M.G.3    Dowzicky, M.J.4    Jones, R.N.5
  • 6
    • 38049141883 scopus 로고    scopus 로고
    • Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections
    • Townsend M.L., Pound M.W., and Drew R.H. Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections. Ther Clin Risk Manag 3 (2007) 1059-1070
    • (2007) Ther Clin Risk Manag , vol.3 , pp. 1059-1070
    • Townsend, M.L.1    Pound, M.W.2    Drew, R.H.3
  • 7
    • 67349167812 scopus 로고    scopus 로고
    • Wyeth Pharmaceuticals Inc, Philadelphia, PA: Wyeth Pharmaceuticals Inc;, Accessed 06.08.08
    • ® product insert. Philadelphia, PA: Wyeth Pharmaceuticals Inc; 2007. http://www.wyeth.com/hcp/tygacil (Accessed 06.08.08).
    • (2007) ® product insert
  • 8
    • 40549101032 scopus 로고    scopus 로고
    • Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the Tigecycline Evaluation and Surveillance Trial
    • Rodloff A.C., Leclercq R., Debbia E.A., Cantón R., Oppenheim B.A., and Dowzicky M.J. Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the Tigecycline Evaluation and Surveillance Trial. Clin Microbiol Infect 14 (2008) 307-314
    • (2008) Clin Microbiol Infect , vol.14 , pp. 307-314
    • Rodloff, A.C.1    Leclercq, R.2    Debbia, E.A.3    Cantón, R.4    Oppenheim, B.A.5    Dowzicky, M.J.6
  • 9
    • 0003344510 scopus 로고    scopus 로고
    • Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard
    • National Committee for Clinical Laboratory Standards, 6th ed, Wayne, PA: NCCLS;
    • National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 6th ed. Document M7-A6. Wayne, PA: NCCLS; 2003.
    • (2003) Document
  • 10
    • 33646696219 scopus 로고    scopus 로고
    • Clinical and Laboratory Standards Institute, 16th ed. Document M100-S16. Wayne, PA: CLSI;
    • Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 16th ed. Document M100-S16. Wayne, PA: CLSI; 2006.
    • (2006) Performance standards for antimicrobial susceptibility testing
  • 11
    • 0037626394 scopus 로고    scopus 로고
    • MYSTIC Study Group (Europe). The activity of meropenem and comparators against Acinetobacter strains isolated from European hospitals, 1997-2000
    • Turner P.J., and Greenhalgh J.M. MYSTIC Study Group (Europe). The activity of meropenem and comparators against Acinetobacter strains isolated from European hospitals, 1997-2000. Clin Microbiol Infect 9 (2003) 563-567
    • (2003) Clin Microbiol Infect , vol.9 , pp. 563-567
    • Turner, P.J.1    Greenhalgh, J.M.2
  • 12
    • 4544327051 scopus 로고    scopus 로고
    • ARPAC Steering Group. Antimicrobial resistance of Acinetobacter spp. in Europe
    • Van Looveren M., and Goossens H. ARPAC Steering Group. Antimicrobial resistance of Acinetobacter spp. in Europe. Clin Microbiol Infect 10 (2004) 684-704
    • (2004) Clin Microbiol Infect , vol.10 , pp. 684-704
    • Van Looveren, M.1    Goossens, H.2
  • 13
    • 54049101716 scopus 로고    scopus 로고
    • A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae
    • Vasilev K., Reshedko G., Orasan R., Sanchez M., Teras J., Babinchak T., et al. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae. J Antimicrob Chemother 62 Suppl 1 (2008) i29-40
    • (2008) J Antimicrob Chemother , vol.62 , Issue.SUPPL. 1
    • Vasilev, K.1    Reshedko, G.2    Orasan, R.3    Sanchez, M.4    Teras, J.5    Babinchak, T.6
  • 14
    • 0141925608 scopus 로고    scopus 로고
    • In vitro susceptibilities of gram-negative bacteria isolated from hospitalized patients in four European countries, Canada, and the United States in 2000-2001 to expanded-spectrum cephalosporins and comparator antimicrobials: implications for therapy
    • Wenzel R.P., Sahm D.F., Thornsberry C., Draghi C.D., Jones M.E., and Karlowsky J.A. In vitro susceptibilities of gram-negative bacteria isolated from hospitalized patients in four European countries, Canada, and the United States in 2000-2001 to expanded-spectrum cephalosporins and comparator antimicrobials: implications for therapy. Antimicrob Agents Chemother 47 (2003) 3089-3098
    • (2003) Antimicrob Agents Chemother , vol.47 , pp. 3089-3098
    • Wenzel, R.P.1    Sahm, D.F.2    Thornsberry, C.3    Draghi, C.D.4    Jones, M.E.5    Karlowsky, J.A.6
  • 15
    • 37249052710 scopus 로고    scopus 로고
    • Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe
    • Cantón R., Novais A., Valverde A., Machado E., Peixe L., Baquero F., et al. Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 14 Suppl 1 (2008) 144-153
    • (2008) Clin Microbiol Infect , vol.14 , Issue.SUPPL. 1 , pp. 144-153
    • Cantón, R.1    Novais, A.2    Valverde, A.3    Machado, E.4    Peixe, L.5    Baquero, F.6
  • 16
    • 38949157167 scopus 로고    scopus 로고
    • Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15
    • Coque T.M., Novais A., Carattoli A., Poirel L., Pitout J., Peixe L., et al. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg Infect Dis 14 (2008) 195-200
    • (2008) Emerg Infect Dis , vol.14 , pp. 195-200
    • Coque, T.M.1    Novais, A.2    Carattoli, A.3    Poirel, L.4    Pitout, J.5    Peixe, L.6
  • 17
    • 0035984795 scopus 로고    scopus 로고
    • Diversity of β-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae
    • Dabernat H., Delmas C., Seguy M., Pelissier R., Faucon G., Bennamani S., et al. Diversity of β-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob Agents Chemother 46 (2002) 2208-2218
    • (2002) Antimicrob Agents Chemother , vol.46 , pp. 2208-2218
    • Dabernat, H.1    Delmas, C.2    Seguy, M.3    Pelissier, R.4    Faucon, G.5    Bennamani, S.6
  • 18
    • 24044504090 scopus 로고    scopus 로고
    • Susceptibility of European β-lactamase-positive and -negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/2003
    • Fluit A.C., Florijn A., Verhoef J., and Milatovic D. Susceptibility of European β-lactamase-positive and -negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/2003. J Antimicrob Chemother 56 (2005) 133-138
    • (2005) J Antimicrob Chemother , vol.56 , pp. 133-138
    • Fluit, A.C.1    Florijn, A.2    Verhoef, J.3    Milatovic, D.4
  • 19
    • 34447256788 scopus 로고    scopus 로고
    • Ampicillin-resistant non-β-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime
    • García-Cobos S., Campos J., Lázaro E., Román F., Cercenado E., Garciá-Rey C., et al. Ampicillin-resistant non-β-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime. Antimicrob Agents Chemother 51 (2007) 2564-2573
    • (2007) Antimicrob Agents Chemother , vol.51 , pp. 2564-2573
    • García-Cobos, S.1    Campos, J.2    Lázaro, E.3    Román, F.4    Cercenado, E.5    Garciá-Rey, C.6
  • 20
    • 21444442865 scopus 로고    scopus 로고
    • Genetic approach to study the relationship between penicillin-binding protein 3 mutations and Haemophilus influenzae β-lactam resistance by using site-directed mutagenesis and gene recombinants
    • Osaki Y., Sanbongi Y., Ishikawa M., Kataoka H., Suzuki T., Maeda K., et al. Genetic approach to study the relationship between penicillin-binding protein 3 mutations and Haemophilus influenzae β-lactam resistance by using site-directed mutagenesis and gene recombinants. Antimicrob Agents Chemother 49 (2005) 2834-2839
    • (2005) Antimicrob Agents Chemother , vol.49 , pp. 2834-2839
    • Osaki, Y.1    Sanbongi, Y.2    Ishikawa, M.3    Kataoka, H.4    Suzuki, T.5    Maeda, K.6
  • 22
    • 34248513134 scopus 로고    scopus 로고
    • Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centres (2005)
    • Sader H.S., Watters A.A., Fritsche T.R., and Jones R.N. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centres (2005). BMC Infect Dis 7 (2007) 9
    • (2007) BMC Infect Dis , vol.7 , pp. 9
    • Sader, H.S.1    Watters, A.A.2    Fritsche, T.R.3    Jones, R.N.4
  • 23
    • 48649085107 scopus 로고    scopus 로고
    • Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis
    • Chou Y.Y., Lin T.Y., Lin J.C., Wang N.C., Peng N.Y., and Chang F.Y. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis. J Microbiol Immunol Infect 41 (2008) 124-129
    • (2008) J Microbiol Immunol Infect , vol.41 , pp. 124-129
    • Chou, Y.Y.1    Lin, T.Y.2    Lin, J.C.3    Wang, N.C.4    Peng, N.Y.5    Chang, F.Y.6
  • 24
    • 34948851810 scopus 로고    scopus 로고
    • Risk factors for development of multiple-class resistance to Streptococcus pneumoniae strains in Belgium over a 10-year period: antimicrobial consumption, population density, and geographic location
    • Van Eldere J., Mera R.M., Miller L.A., Poupard J.A., and Amrine-Madsen H. Risk factors for development of multiple-class resistance to Streptococcus pneumoniae strains in Belgium over a 10-year period: antimicrobial consumption, population density, and geographic location. Antimicrob Agents Chemother 51 (2007) 3491-3497
    • (2007) Antimicrob Agents Chemother , vol.51 , pp. 3491-3497
    • Van Eldere, J.1    Mera, R.M.2    Miller, L.A.3    Poupard, J.A.4    Amrine-Madsen, H.5
  • 26
    • 9444250412 scopus 로고    scopus 로고
    • Emerging resistance among bacterial pathogens in the intensive care unit-a European and North American Surveillance study (2000-2002)
    • Jones M.E., Draghi D.C., Thornsberry C., Karlowsky J.A., Sahm D.F., and Wenzel R.P. Emerging resistance among bacterial pathogens in the intensive care unit-a European and North American Surveillance study (2000-2002). Ann Clin Microbiol Antimicrob 3 (2004) 14
    • (2004) Ann Clin Microbiol Antimicrob , vol.3 , pp. 14
    • Jones, M.E.1    Draghi, D.C.2    Thornsberry, C.3    Karlowsky, J.A.4    Sahm, D.F.5    Wenzel, R.P.6
  • 27
    • 23644449109 scopus 로고    scopus 로고
    • Tigecycline Evaluation and Surveillance Trial (TEST Program) Group. In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004)
    • Hoban D.J., Bouchillon S.K., Johnson B.M., Johnson J.L., and Dowzicky M.J. Tigecycline Evaluation and Surveillance Trial (TEST Program) Group. In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004). Diagn Microbiol Infect Dis 52 (2005) 215-227
    • (2005) Diagn Microbiol Infect Dis , vol.52 , pp. 215-227
    • Hoban, D.J.1    Bouchillon, S.K.2    Johnson, B.M.3    Johnson, J.L.4    Dowzicky, M.J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.